Journal Club 2024

journal club image

Want to be a Journal Club Presenter?

The next call for the January-June 2025 session speakers is now open.

Find out more and apply here!

Next HOPA Journal Club

Thursday, October 17, 2024 at 12 p.m. Central Time

Listen to critical evaluations of hematology/oncology pharmacy publications resented by PGY2 Oncology Residents.

Reserve your spot for October's Journal Club!

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial

Ho Jun Lee, PharmD, PGY-2 Oncology Pharmacy Resident,

Kaiser Permanente — San Diego, San Diego, CA

Article: 

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial

Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial

Christy Ilia, PharmD, PGY2 Oncology Pharmacy Resident,

Boston Medical Center, Boston, MA

Article:

Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial

Reserve your spot for October's Journal Club!

Featured Articles

Late Breaking News

Clinical Oncology Pharmacy Technician: Impact of a New Role on Pharmacy and Patient Metrics at a Large Academic Cancer Center

September 20, 2024

A recently published article details the impact of having an inpatient clinical oncology pharmacy technician program.

Visual of data being collected

Late Breaking News

Oncology Pharmacy Staffing Survey Across Practice Settings in the United States

September 19, 2024

The results of a recently published pharmacy staffing model survey has brought new insights into oncology pharmacy operations across the country.

Digital medical illustration of a bladder

Tools and Resources

Pharmacist's Application to Practice: Nogapendekin alfa inbakicept-pmln

August 27, 2024

Devan Parker, PharmD, PGY2 Oncology Pharmacy Resident and Juliana Leedy, PharmD, MS, Clinical Oncology Pharmacist, The University of Alabama at Birmingham (UAB) Hospital, Birmingham, Alabama writes about nogapendekin alfa inbakicept-pmln.